Gilead Sciences (GILD) Short Interest Ratio & Short Volume → I’m afraid WWIII is a very real possibility (From Porter & Company) (Ad) Free GILD Stock Alerts $67.72 -0.14 (-0.21%) (As of 05/17/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Gilead Sciences Short Interest DataCurrent Short Volume21,160,000 sharesPrevious Short Volume21,180,000 sharesChange Vs. Previous Month-0.09%Dollar Volume Sold Short$1.38 billionShort Interest Ratio / Days to Cover2.9Last Record DateApril 30, 2024Outstanding Shares1,245,850,000 sharesPercentage of Shares Shorted1.70%Today's Trading Volume3,579,110 sharesAverage Trading Volume7,566,109 sharesToday's Volume Vs. Average47% Short Selling Gilead Sciences ? Sign up to receive the latest short interest report for Gilead Sciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatGILD Short Interest Over TimeGILD Days to Cover Over TimeGILD Percentage of Float Shorted Over Time Ad Chaikin AnalyticsMissed NVDA? Buy this AI stock NOWAfter Nvidia's record-breaking earnings surge, Wall Street is now selling the stock at the fastest pace in seven months. So if you currently own NVIDIA (NVDA)... Or were thinking of buying it in the weeks ahead... I urge you to review my recent interview with 50-year Wall Street legend Marc Chaikin.You can watch it here. Gilead Sciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202421,160,000 shares $1.38 billion -0.1%N/A2.9 $65.20 4/15/202421,180,000 shares $1.43 billion -6.2%N/A2.9 $67.75 3/31/202422,570,000 shares $1.65 billion +17.3%N/A3 $73.25 3/15/202419,250,000 shares $1.42 billion -2.1%1.6%2.7 $73.69 2/29/202419,670,000 shares $1.42 billion -1.1%1.6%2.7 $72.10 2/15/202419,880,000 shares $1.46 billion +27.0%1.6%2.8 $73.37 Get the Latest News and Ratings for GILD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Gilead Sciences and its competitors with MarketBeat's FREE daily newsletter. 1/31/202415,660,000 shares $1.23 billion -8.6%1.3%2.2 $78.26 1/15/202417,140,000 shares $1.48 billion +0.6%1.4%2.6 $86.38 12/31/202317,040,000 shares $1.38 billion -7.9%N/A2.7 $81.01 12/15/202318,500,000 shares $1.49 billion +6.2%N/A3 $80.33 11/30/202317,420,000 shares $1.33 billion -3.9%N/A3 $76.60 11/15/202318,130,000 shares $1.36 billion -7.0%N/A3.3 $75.04 10/31/202319,500,000 shares $1.53 billion -4.2%1.6%3.6 $78.54 10/15/202320,350,000 shares $1.58 billion +0.5%1.6%3.9 $77.65 9/30/202320,240,000 shares $1.52 billion +10.4%1.6%3.8 $74.94 9/15/202318,330,000 shares $1.39 billion +0.4%1.5%3.3 $75.67 8/31/202318,250,000 shares $1.40 billion -7.0%1.5%3.2 $76.48 8/15/202319,630,000 shares $1.56 billion +4.2%1.6%3.4 $79.64 7/31/202318,840,000 shares $1.43 billion +7.2%N/A3.3 $76.14 7/15/202317,570,000 shares $1.36 billion +1.3%N/A3 $77.19 6/30/202317,340,000 shares $1.34 billion +6.3%N/A3.2 $77.07 6/15/202316,320,000 shares $1.29 billion +6.8%N/A3 $79.00 5/31/202315,280,000 shares $1.18 billion -15.0%N/A2.7 $76.94 5/15/202317,980,000 shares $1.41 billion -6.7%N/A3.4 $78.38 4/30/202319,280,000 shares $1.59 billion +26.4%N/A3.4 $82.21 4/15/202315,250,000 shares $1.27 billion -1.5%N/A2.6 $83.00 3/31/202315,480,000 shares $1.28 billion +1.8%N/A2.6 $82.97 3/15/202315,200,000 shares $1.21 billion -2.9%N/A2.5 $79.65 2/28/202315,660,000 shares $1.26 billion -0.6%N/A2.3 $80.53 2/15/202315,760,000 shares $1.34 billion +3.9%N/A2.3 $85.05 1/31/202315,170,000 shares $1.27 billion +1.6%N/A2.1 $83.94 1/15/202314,930,000 shares $1.29 billion -8.0%N/A1.9 $86.27 12/30/202216,220,000 shares $1.39 billion +9.9%N/A2.1 $85.85 12/15/202214,760,000 shares $1.28 billion -16.0%N/A1.8 $86.58 11/30/202217,560,000 shares $1.54 billion -15.3%N/A2.1 $87.83 11/15/202220,730,000 shares $1.72 billion +8.7%N/A2.5 $83.00 10/31/202219,070,000 shares $1.50 billion +15.8%N/A2.4 $78.46 10/15/202216,470,000 shares $1.09 billion +0.1%N/A2.3 $66.17 9/30/202216,450,000 shares $1.01 billion -1.4%N/A2.4 $61.69 9/15/202216,690,000 shares $1.08 billion -0.5%N/A2.5 $65.00Elon to Transform U.S. Economy? (Ad)A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it. GILD Short Interest - Frequently Asked Questions What is Gilead Sciences' current short interest? Short interest is the volume of Gilead Sciences shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 21,160,000 shares of GILD short. Learn More on Gilead Sciences' current short interest. What is a good short interest ratio for Gilead Sciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. GILD shares currently have a short interest ratio of 3.0. Learn More on Gilead Sciences's short interest ratio. Which institutional investors are shorting Gilead Sciences? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Gilead Sciences: Walleye Trading LLC, Jane Street Group LLC, PEAK6 Investments LLC, Twin Tree Management LP, BNP Paribas Financial Markets, Concourse Financial Group Securities Inc., Simplex Trading LLC, IMC Chicago LLC, Nomura Holdings Inc., and Readystate Asset Management LP. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Gilead Sciences' short interest increasing or decreasing? Gilead Sciences saw a decrease in short interest in April. As of April 30th, there was short interest totaling 21,160,000 shares, a decrease of 0.1% from the previous total of 21,180,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Gilead Sciences' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Gilead Sciences: Seagen Inc. (5.10%), Biogen Inc. (2.18%), Neurocrine Biosciences, Inc. (1.82%), Bio-Techne Co. (3.76%), Qiagen (1.32%), Repligen Co. (8.51%), CRISPR Therapeutics AG (17.18%), Denali Therapeutics Inc. (8.16%), Amgen Inc. (1.82%), Moderna, Inc. (6.26%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Gilead Sciences stock? Short selling GILD is an investing strategy that aims to generate trading profit from Gilead Sciences as its price is falling. GILD shares are trading down $0.14 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Gilead Sciences? A short squeeze for Gilead Sciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of GILD, which in turn drives the price of the stock up even further. How often is Gilead Sciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GILD, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: SGEN Short Interest BIIB Short Interest NBIX Short Interest TECH Short Interest QGEN Short Interest RGEN Short Interest CRSP Short Interest DNLI Short Interest AMGN Short Interest MRNA Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:GILD) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersObama’s Forever Term [exposed]Porter & CompanyCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaMissed NVDA? Buy this AI stock NOWChaikin AnalyticsMost important medical advance in 100 yearsThe Oxford ClubThe Presidential candidate you should REALLY be worried aboutStansberry ResearchForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressShocking: One AI startup's revenue could surge 4,735%Manward Press